Home › Core › ISCC-IDs › 28C5eT5k4EaHT

View ISCC-ID

Core Data

28C5eT5k4EaHT
ISCC-ID - digital asset identifier
CCdSNQSBQtDsk-CT9VmG62GzBCV-CDYPmthUFhSj6-CR9ez7uPDo3ZC
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

allogeneic stem cell transplantation for chronic myeloid leukaemia is safe and effective in high risk patients following second

Ledger Reference

coblo
Source Ledger/Blockchain
12400017
N-th ISCC Decleration on source ledger
3fbe34e1fa42fd10fc33da7527761133bb202370cd39e3545e13fb20d0e963c1
Hash of block that includes the ISCC-DECLARATION
e0425e7e500c50983f0331b3bbb56f579ff4417fc4626a696be43e8bd1b0fd57
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Allogeneic stem cell transplantation for chronic myeloid leukaemia is safe and effective in high risk patients following second generation tyrosine kinase inhibitors: A single centre's experience", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Anne-Louise Latif", "@type": "Person"}, {"name": "Grant McQuaker", "@type": "Person"}, {"name": "Anne Parker", "@type": "Person"}, {"name": "Andrew Clark", "@type": "Person"}, {"name": "Mhairi Copland", "@type": "Person"}], "license": "cc-by-nc-nd", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3850380?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Elsevier BV", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1016/j.lrr.2013.05.001", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCdSNQSBQtDsk-CT9VmG62GzBCV-CDYPmthUFhSj6-CR9ez7uPDo3ZC", "propertyID": "ISCC"}], "datePublished": "2013-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close